Skip to main content
logo
Reviva Pharmaceuticals Holdings, Inc. (RVPH)
OTCMKTS · Delayed Price · Currency is USD
0.3500
-0.0415 (-10.60%)
At close: Oct 30, 2026

RVPH Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-13.02-19.86-29.92-39.26-28.26-8.52
Stock-Based Compensation
1.712.231.633.410.180.15
Other Operating Activities
-0.02-0.09-0.720.240.19-1.59
Change in Accounts Payable
-2.57-3.412.290.333.01-0.5
Change in Other Net Operating Assets
-3.41-3.46-6.836.965.92-0.2
Operating Cash Flow
-17.3-24.59-33.54-28.32-18.96-10.67
Operating Cash Flow Growth
------

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-0.410.980.67--
Total Debt Issued
0.410.410.980.67--
Short-Term Debt Repaid
--0.46-0.52-0.67--
Total Debt Repaid
-0.38-0.46-0.52-0.67--
Net Debt Issued (Repaid)
0.03-0.050.46---
Issuance of Common Stock
26.825.6123.1933.177.7931.6
Financing Cash Flow
26.8325.5623.6533.177.7931.6

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
9.530.96-9.894.85-11.1720.93

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Levered Free Cash Flow
-13.69-17.14-21.54-14.01-8.54-6.87
Unlevered Free Cash Flow
-13.69-17.13-21.52-13.99-8.54-6.87

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.010.010.020.03--
Cash Income Tax Paid
0000.02-0
Change in Working Capital
-5.98-6.87-4.547.288.93-0.7